ZSAN logo

Zosano Pharma (ZSAN) EBITDA

Annual EBITDA

-$27.98 M
+$3.24 M+10.37%

December 31, 2021

Summary

Performance

1-Year Change

+10.37%

3-Year Change

+18.21%

5-Year Change

-8.74%

15-Year Change

-8.74%

ZSAN EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$4.22 M
ZSAN annual EBITDA is currently -763.62% below its historical high of $4.22 million

3-Year Low

-$27.98 M
ZSAN annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
ZSAN previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
ZSAN next annual earnings announcement has not yet been scheduled

OtherZSANprofitabilitymetrics:

Annual Revenue

$785.00 K
ZSAN annual revenue is $785.00 thousand

Annual Net Income

-$29.93 M
ZSAN annual net profit is -$29.93 million

Annual EBIT

-$29.74 M
ZSAN annual earnings before interest & taxes is -$29.74 million

Annual EPS

-$9.45
ZSAN annual earnings per share is -$9.45

Quarterly EBITDA

-$33.09 M
-$26.60 M-409.80%

March 31, 2022

Summary

Performance

3-Month Change

-409.8%

1-Year Change

-334.77%

3-Year Change

-258.81%

5-Year Change

-440.62%

ZSAN Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$630.00 K
ZSAN quarterly EBITDA is currently -5351.75% below its historical high of $630.00 thousand

3-Year Low

-$33.09 M
ZSAN quarterly EBITDA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2022
ZSAN previous earnings announcement was published on Mar 31, 2022

Next Quarterly Earnings Report Date

N/A
ZSAN next earnings announcement has not yet been scheduled

OtherZSANprofitabilitymetrics:

Quarterly Revenue

$132.00 K
ZSAN quarterly revenue is $132.00 thousand

Quarterly Net Income

-$33.41 M
ZSAN quarterly net profit is -$33.41 million

Quarterly EBIT

-$33.34 M
ZSAN quarterly earnings before interest & taxes is -$33.34 million

Quarterly EPS

-$7.86
ZSAN quarterly earnings per share is -$7.86

TTM EBITDA

-$53.46 M
-$25.48 M-91.03%

March 31, 2022

Summary

Performance

3-Month Change

-91.03%

1-Year Change

-75.15%

3-Year Change

-46.94%

5-Year Change

-46.94%

ZSAN TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$630.00 K
ZSAN TTM EBITDA is currently -8585.87% below its historical high of $630.00 thousand

3-Year Low

-$53.46 M
ZSAN TTM EBITDA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2022
ZSAN previous earnings announcement was published on Mar 31, 2022

Next Quarterly Earnings Report Date

N/A
ZSAN next earnings announcement has not yet been scheduled

OtherZSANprofitabilitymetrics:

TTM Revenue

$659.00 K
ZSAN TTM revenue is $659.00 thousand

TTM Net Income

-$55.19 M
ZSAN TTM net profit is -$55.19 million

TTM EBIT

-$55.03 M
ZSAN TTM earnings before interest & taxes is -$55.03 million

TTM EPS

-$14.51
ZSAN TTM earnings per share is -$14.51

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$27.98 M
ZSAN annual EBITDA is -$27.98 million

Annual Net Income

-$29.93 M
ZSAN annual net profit is -$29.93 million

Annual Interest Expense

$189.00 K
ZSAN annual interest expense is $189.00 thousand

Annual Income Tax

$0.00
ZSAN annual income tax is $0.00

Annual D&A

$1.75 M
ZSAN annual depreciation & amortization is $1.75 million

ZSAN EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+10.4%-334.8%-75.2%
3 y3 years+18.2%-258.8%-46.9%
5 y5 years-8.7%-440.6%-46.9%

ZSAN EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat low+409.8%at low+91.0%at low
5 y5-yearat high+30.0%+481.7%at low+91.0%at low
alltimeall time-763.6%+30.0%-5351.7%at low-8585.9%at low

Zosano Pharma EBITDA History

DateAnnualQuarterlyTTM
Mar 2022
-
-$33.09 M(+409.8%)
-$53.46 M(+91.0%)
Dec 2021
-$27.98 M(-10.4%)
-$6.49 M(-20.8%)
-$27.98 M(-3.5%)
Sep 2021
-
-$8.20 M(+44.1%)
-$29.00 M(+0.5%)
Jun 2021
-
-$5.69 M(-25.3%)
-$28.85 M(-5.5%)
Mar 2021
-
-$7.61 M(+1.4%)
-$30.52 M(-2.2%)
Dec 2020
-$31.22 M(-14.2%)
-$7.51 M(-6.7%)
-$31.22 M(-3.4%)
Sep 2020
-
-$8.05 M(+9.3%)
-$32.33 M(-4.1%)
Jun 2020
-
-$7.36 M(-11.4%)
-$33.70 M(-5.0%)
Mar 2020
-
-$8.31 M(-3.5%)
-$35.47 M(-2.5%)
Dec 2019
-$36.38 M(+6.3%)
-$8.61 M(-8.7%)
-$36.38 M(-3.6%)
Sep 2019
-
-$9.43 M(+3.3%)
-$37.74 M(+4.3%)
Jun 2019
-
-$9.13 M(-1.0%)
-$36.18 M(+1.7%)
Mar 2019
-
-$9.22 M(-7.5%)
-$35.58 M(+4.0%)
Dec 2018
-$34.22 M(+33.0%)
-$9.96 M(+26.7%)
-$34.22 M(+10.8%)
Sep 2018
-
-$7.87 M(-7.7%)
-$30.87 M(+2.6%)
Jun 2018
-
-$8.53 M(+8.5%)
-$30.08 M(+9.5%)
Mar 2018
-
-$7.86 M(+18.7%)
-$27.47 M(+6.7%)
Dec 2017
-$25.73 M
-$6.62 M(-6.5%)
-$25.73 M(-0.6%)
DateAnnualQuarterlyTTM
Sep 2017
-
-$7.08 M(+19.6%)
-$25.89 M(+2.2%)
Jun 2017
-
-$5.92 M(-3.3%)
-$25.33 M(+1.2%)
Mar 2017
-
-$6.12 M(-9.7%)
-$25.03 M(-4.0%)
Dec 2016
-$26.09 M(+9.1%)
-$6.78 M(+4.0%)
-$26.09 M(+0.8%)
Sep 2016
-
-$6.51 M(+15.8%)
-$25.88 M(-4.7%)
Jun 2016
-
-$5.63 M(-21.6%)
-$27.15 M(-1.5%)
Mar 2016
-
-$7.18 M(+9.3%)
-$27.57 M(+15.3%)
Dec 2015
-$23.92 M(+155.8%)
-$6.57 M(-15.6%)
-$23.92 M(+20.0%)
Sep 2015
-
-$7.78 M(+28.5%)
-$19.92 M(+37.5%)
Jun 2015
-
-$6.05 M(+72.1%)
-$14.49 M(+31.0%)
Mar 2015
-
-$3.52 M(+36.8%)
-$11.06 M(+18.3%)
Dec 2014
-$9.35 M(+24.0%)
-$2.57 M(+9.5%)
-$9.35 M(-13.5%)
Sep 2014
-
-$2.35 M(-10.5%)
-$10.82 M(+27.7%)
Jun 2014
-
-$2.62 M(+45.3%)
-$8.47 M(+44.9%)
Mar 2014
-
-$1.81 M(-55.3%)
-$5.84 M(+71.5%)
Dec 2013
-$7.54 M(-278.8%)
-$4.04 M(-740.8%)
-$3.41 M(-640.8%)
Mar 2013
-
$630.00 K
$630.00 K
Dec 2012
$4.22 M
-
-

FAQ

  • What is Zosano Pharma annual EBITDA?
  • What is the all time high annual EBITDA for Zosano Pharma?
  • What is Zosano Pharma annual EBITDA year-on-year change?
  • What is Zosano Pharma quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Zosano Pharma?
  • What is Zosano Pharma quarterly EBITDA year-on-year change?
  • What is Zosano Pharma TTM EBITDA?
  • What is the all time high TTM EBITDA for Zosano Pharma?
  • What is Zosano Pharma TTM EBITDA year-on-year change?

What is Zosano Pharma annual EBITDA?

The current annual EBITDA of ZSAN is -$27.98 M

What is the all time high annual EBITDA for Zosano Pharma?

Zosano Pharma all-time high annual EBITDA is $4.22 M

What is Zosano Pharma annual EBITDA year-on-year change?

Over the past year, ZSAN annual EBITDA has changed by +$3.24 M (+10.37%)

What is Zosano Pharma quarterly EBITDA?

The current quarterly EBITDA of ZSAN is -$33.09 M

What is the all time high quarterly EBITDA for Zosano Pharma?

Zosano Pharma all-time high quarterly EBITDA is $630.00 K

What is Zosano Pharma quarterly EBITDA year-on-year change?

Over the past year, ZSAN quarterly EBITDA has changed by -$25.48 M (-334.77%)

What is Zosano Pharma TTM EBITDA?

The current TTM EBITDA of ZSAN is -$53.46 M

What is the all time high TTM EBITDA for Zosano Pharma?

Zosano Pharma all-time high TTM EBITDA is $630.00 K

What is Zosano Pharma TTM EBITDA year-on-year change?

Over the past year, ZSAN TTM EBITDA has changed by -$22.94 M (-75.15%)